NPPA has observed that these devices are important in managing Covid-19 pandemic, not only for home use, but in hospital management too. The National Pharmaceutical Pricing Authority (NPPA) has reported 88% price reduction in one-third of domestic brands of medical devices following trade margin cap at 70% for pulse oximeter, blood pressure monitoring machine, nebuliser, … Read more
According to NPPA, 620 products or brands have reported downward revision of MRP by up to 88% after the trade margin rationalization of these 5 medical devices. Medical Technology Association of India (MTaI), which is an association of research-based medical technology companies, has hailed Government’s trade margin rationalization (TMR) and stated that this will bring … Read more
The manufacturers of these five medical devices selling at price higher than the Maximum Retail Price shall revise the prices downward, not exceeding the MRP computed by using prescribed formula. (Photo source: IE) The National Pharmaceutical Pricing Authority (NPPA) has capped the price of five medical devices namely Pulse Oximeter, Blood Pressure Monitoring Machine, Nebulizer, … Read more